iSAM Funds UK Ltd Invests $242,000 in Perrigo Company plc (NYSE:PRGO)

iSAM Funds UK Ltd bought a new position in shares of Perrigo Company plc (NYSE:PRGO) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 9,421 shares of the company’s stock, valued at approximately $242,000.

Several other hedge funds also recently made changes to their positions in PRGO. Barclays PLC increased its holdings in shares of Perrigo by 44.8% during the third quarter. Barclays PLC now owns 120,502 shares of the company’s stock worth $3,160,000 after purchasing an additional 37,268 shares during the period. Nisa Investment Advisors LLC boosted its position in shares of Perrigo by 10.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 304,948 shares of the company’s stock worth $7,840,000 after acquiring an additional 28,843 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Perrigo during the 4th quarter worth approximately $691,000. Janney Montgomery Scott LLC boosted its position in shares of Perrigo by 39.1% during the 4th quarter. Janney Montgomery Scott LLC now owns 90,624 shares of the company’s stock worth $2,330,000 after acquiring an additional 25,472 shares in the last quarter. Finally, Sound Income Strategies LLC boosted its position in shares of Perrigo by 28.6% during the 4th quarter. Sound Income Strategies LLC now owns 482,811 shares of the company’s stock worth $12,413,000 after acquiring an additional 107,427 shares in the last quarter. 95.91% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $33.00.

Perrigo Stock Performance

Shares of Perrigo stock opened at $27.42 on Wednesday. Perrigo Company plc has a fifty-two week low of $23.14 and a fifty-two week high of $30.93. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The firm has a market capitalization of $3.77 billion, a P/E ratio of -23.44 and a beta of 0.45. The company’s 50 day moving average price is $26.26 and its two-hundred day moving average price is $26.17.

Perrigo (NYSE:PRGO) last issued its earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.56 by $0.04. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same quarter last year, the business posted $0.29 earnings per share. The company’s quarterly revenue was down 3.5% on a year-over-year basis. On average, equities analysts forecast that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th will be issued a dividend of $0.29 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.23%. Perrigo’s dividend payout ratio (DPR) is presently -88.55%.

Insider Transactions at Perrigo

In other news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. The trade was a 18.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.70% of the stock is owned by company insiders.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.